| Product NDC: | 60505-6080 |
| Proprietary Name: | FONDAPARINUX SODIUM |
| Non Proprietary Name: | fondaparinux sodium |
| Active Ingredient(s): | 7.5 mg/.6mL & nbsp; fondaparinux sodium |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-6080 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021345 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110718 |
| Package NDC: | 60505-6080-4 |
| Package Description: | 10 SYRINGE in 1 CARTON (60505-6080-4) > .6 mL in 1 SYRINGE (60505-6080-0) |
| NDC Code | 60505-6080-4 |
| Proprietary Name | FONDAPARINUX SODIUM |
| Package Description | 10 SYRINGE in 1 CARTON (60505-6080-4) > .6 mL in 1 SYRINGE (60505-6080-0) |
| Product NDC | 60505-6080 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fondaparinux sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20110718 |
| Marketing Category Name | NDA |
| Labeler Name | Apotex Corp. |
| Substance Name | FONDAPARINUX SODIUM |
| Strength Number | 7.5 |
| Strength Unit | mg/.6mL |
| Pharmaceutical Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |